Isolated heart perfusion according to Langendorff-Still viable in the new millennium

Journal of Pharmacological and Toxicological Methods

Volumn 55, Issue 2, 2007, Pages 113-126

  Skrzypiec Spring, Monika ^a   Grotthus, Bartosz ^a   Szelag, Adam ^a   Schulz, Richard ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Arrhythmia; Ischemia reperfusion; Isolated heart; Matrix metalloproteinases; Method of Langendorff preparation; Perfusion; Rat

Indexed keywords

ACETYLCHOLINE; CALCIUM ION; OXYGEN;

AORTA VALVE; ARTICLE; ASCENDING AORTA; CANNULA; CHRONOTROPISM; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; COST; ELECTRIC ACTIVITY; GERMANY; HEART ATRIUM; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PRESERVATION; HEART TRANSPLANTATION; ISOLATED HEART; MAMMAL; MEASUREMENT; NONHUMAN; NUTRIENT; REPERFUSION INJURY; REPRODUCIBILITY; TEMPERATURE SENSITIVITY; VAGUS NERVE; VAGUS NERVE STIMULATION;

ANIMALS; CARDIOLOGY; CORONARY CIRCULATION; HEART; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MAMMALS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; PERFUSION;

ANURA; MAMMALIA; RATTUS;

EID: 33846876720     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2006.05.006     Document Type: Article

References (75)

1. Anderson P.G., Digerness S.B., Sklar J.L., and Boor P.J. Use of the isolated perfused heart for evaluation of cardiac toxicity. Toxicologic Pathology 18 (1990) 497-510
2. Avkiran M., and Curtis M.J. Independent dual perfusion of left and right coronary arteries in isolated rat hearts. American Journal of Physiology 261 (1991) H2082-H2090
3. Baker K.E., and Curtis M.J. Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonism. British Journal of Pharmacology 142 (2004) 352-366
4. Belke D.D., Larsen T.S., Lopaschuk G.D., and Severson D.L. Glucose and fatty acid metabolism in the isolated working mouse heart. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 277 (1999) R1210-R1217
5. Benzi R.H., and Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Attenuation by ruthenium red administered during reperfusion. Circulation Research 71 (1992) 567-576
6. Bergmann S.R., Clark R.E., and Sobel B.E. An improved isolated heart preparation for external assessment of myocardial metabolism. American Journal of Physiology 236 (1979) 644-661
7. Bowditch H.P. Über die Eigenthümlichkeiten der Reizbarkeit, welche die Muskelfasern des Herzens zeigen. Berichte über die Verhandlungen der Königlich Sächsischen Gesellschaft zu Leipzig. Mathematisch-Physische Classe 23 (1871) 652-689
8. Braunwald E., and Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66 (1982) 1146-1149
9. Broadley K.J. The Langendorff heart preparation-reappraisal of its role as a research and teaching model for coronary vasoactive drugs. Journal of Pharmacological Methods 2 (1979) 143-156
10. Cheung P.Y., Sawicki G., Wozniak M., Wang W., Radomski M.W., and Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101 (2000) 1833-1839
11. Clements-Jewery H., Hearse D.J., and Curtis M.J. Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart. British Journal of Pharmacology 135 (2002) 807-815
12. Clements-Jewery H., Hearse D.J., and Curtis M.J. The isolated blood-perfused rat heart: an inappropriate model for the study of ischemia- and infarction-related ventricular fibrillation. British Journal of Pharmacology 137 (2002) 1089-1099
13. Coats J. Wie ändern sich durch die Erregung des n. vagus die Arbeit und die innern Reize des Herzens? Berichte über die Verhandlungen der Königlich Sächsischen Gesellschaft zu Leipzig. Mathematisch-Physische Classe 21 (1869) 360-391
14. Conte J.V., and Baumgartner W.A. Overview and future practice patterns in cardiac and pulmonary preservation. Journal of Cardiac Surgery 15 (2000) 91-107
15. Curtis M.J. Characterization, utilization and clinical relevance of isolated perfused heart models of ischemia-induced ventricular fibrillation. Cardiovascular Research 39 (1998) 194-215
16. Curtis M.J., and Ellwood A.J. The role of shear stress-independent release of nitric oxide in mediating drug-induced coronary vasodilatation can be assessed in the constant pressure Langendorff preparation. Medical Science Research 26 (1998) 79-81
17. Curtis M.J., Macleod B.A., Tabrizchi R., and Walker M.J.A. An improved perfusion apparatus for small animal hearts. Journal of Pharmacological Methods 15 (1986) 87-94
18. Cyon E. Über den Einfluss der Temperaturänderungen auf Zahl, Dauer und Stärke der Herzschläge. Berichte über die Verhandlungen der Königlich Sächsischen Gesellschaft der Wissenschaften zu Leipzig. Mathematisch-Physische Classe 18 (1866) 256-306
19. de Leiris J., Harding D.P., and Pestre S. The isolated perfused rat heart: a model for studying myocardial hypoxia or ischaemia. Basic Research in Cardiology 79 (1984) 313-321
20. Dobsak P., Courderot-Masuyer C., Zeller M., Vergely C., Laubriet A., Assem M., et al. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. Journal of Cardiovascular Pharmacology 34 (1999) 651-659
21. Doring H.J., and Dehnert H. The isolated perfused heart according to Langendorff (1987), BVM-BiomesstechnicVerlag
22. Dowell J.D., Rubart M., Pasumarthi K.B., Soonpaa M.H., and Field L.J. Myocyte and myogenic stem cell transplantation in the heart. Cardiovascular Research 58 (2003) 336-350
23. Ferdinandy P., Panas D., and Schulz R. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. American Journal of Physiology 276 (1999) H1861-H1867
24. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. British Journal of Pharmacology 138 (2003) 532-543
25. Ferrari R., Cargnoni A., Bernocchi P., Pasini E., Curello S., Ceconi C., et al. Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. Circulation 94 (1996) 2587-2596
26. Fischer-Rasokat U., Beyersdorf F., and Doenst T. Insulin addition after ischemia improves recovery of function equal to ischemic preconditioning in rat heart. Basic Research in Cardiology 98 (2003) 329-336
27. Fitton T.P., Wei C., Lin R., Bethea B.T., Barreiro C.J., Amado L., et al. Impact of 24 h continuous hypothermic perfusion on heart preservation by assessment of oxidative stress. Clinical Transplantation 18 Suppl 12 (2004) 22-27
28. Granger H.J. Cardiovascular physiology in the twentieth century: great strides and missed opportunities. American Journal of Physiology 275 (1998) 1925-1936
29. Hamlin R.L., Cruze C.A., Mittelstadt S.W., Kijtawornrat A., Keene B.W., Roche B.M., et al. Sensitivity and specificity of isolated perfused guinea pig heart to test for drug-induced lengthening of QTc. Journal of Pharmacological and Toxicological Methods 49 (2004) 15-23
30. Hearse D.J., and Sutherland F.J. Experimental models for the study of cardiovascular function and disease. Pharmacological Research 41 (2000) 597-603
31. Hill A.J., Laske T.G., Coles Jr. J.A., Sigg D.C., Skadsberg N.D., Vincent S.A., et al. In vitro studies of human hearts. Annals of Thoracic Surgery 79 (2005) 168-177
32. Hoenicke E.M., Peterseim D.S., Ducko C.T., Sun X., and Damiano R.J. Donor heart preservation with the potassium channel opener pinacidil: comparison with University of Wisconsin and St. Thomas' solution. Journal of Heart and Lung Transplantation 19 (2000) 286-297
33. How O.J., Aasum E., Kunnathu S., Severson D.L., Myhre E.S., and Larsen T.S. Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts. American Journal of Physiology. Heart and Circulatory Physiology 288 (2005) H2979-H2985
34. Jones B.U., Serna D.L., Smulowitz P., Connolly P., Farber A., Beckham G., et al. Extended ex vivo myocardial preservation in the beating state using a novel polyethylene glycolated bovine hemoglobin perfusate based solution. ASAIO Journal 49 (2003) 388-394
35. Kaneda T., Zhang Z.W., Ogawa T., Otaki M., and Saga T. Pretreatment of donors with endothelin receptor antagonist TAK-044 improves cardiac functional recovery following preservation with University of Wisconsin solution. Scandinavian Cardiovascular Journal 36 (2002) 105-107
36. Langendorff O. Untersuchungen am überlebenden Säugetierherzen. Pflügers Archiv 61 (1898) 291-332
37. Lee M.S., Lill M., and Makkar R.R. Stem cell transplantation in myocardial infarction. Reviews in Cardiovascular Medicine 5 (2004) 82-98
38. Loewi O. Über humorale Übertragbarkeit der Herznervenwirkung. I. Mitteilung. Archives of Physiology 189 (1921) 239-242
39. Longnus S.L., Wambolt R.B., Barr R.L., Lopaschuk G.D., and Allard M.F. Regulation of myocardial fatty acid oxidation by substrate supply. American Journal of Physiology. Heart and Circulatory Physiology 281 (2001) H1561-H1567
40. Manning A.S., Hearse D.J., Dennis S.C., Bullock G.R., and Coltart D.J. Myocardial ischaemia: an isolated, globally perfused rat heart model for metabolic and pharmacological studies. European Journal of Cardiology 11 (1980) 1-21
41. McLaren A.J., and Friend P.J. Trends in organ preservation. Transplant International 16 (2003) 701-708
42. Menasche P. Cell transplantation in myocardium. Annals of Thoracic Surgery 75 (2003) 20-28
43. Murphy A.M., Kogler H., Georgakopoulos D., McDonough J.L., Kass D.A., Van Eyk J.E., et al. Transgenic mouse model of stunned myocardium. Science 287 (2000) 488-491
44. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
45. Nydegger U.E., Carrel T., Laumonier T., and Mohacsi P. New concepts in organ preservation. Transplant Immunology 9 (2002) 215-225
46. Ohno N., Fedak P.W., Weisel R.D., Mickle D.A., Fujii T., and Li R.K. Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function. Journal of Thoracic and Cardiovascular Surgery 126 (2003) 1537-1548
47. Paquin J., Aouffen M., De Grandpre E., Nadeau R., Langlois D., and Mateescu M.A. Neuroprotective and cardioprotective actions of an association of pyruvate, vitamin E and fatty acids. Arzneimittelforschung 55 (2005) 359-369
48. Pasini E., Solfrini R., Bachetti T., Marino M., Bernocchi P., Visioli F., et al. The blood perfused isolated heart: characterization of the model. Basic Research in Cardiology 94 (1999) 215-222
49. Patterson S.W., and Starling E.H. On the mechanical factors which determine the output of the ventricles. Journal of Physiology 48 (1914) 357-379
50. Rees S.A., and Curtis M.J. Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts. British Journal of Pharmacology 108 (1993) 139-145
51. Rees S.A., and Curtis M.J. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate. Circulation 87 (1993) 1979-1989
52. Ryugo M., Sawa Y., Ono M., Fukushima N., Aleshin A.N., Mizuno S., et al. Myocardial protective effect of human recombinant hepatocyte growth factor for prolonged heart graft preservation in rats. Transplantation 78 (2004) 1153-1158
53. Sambandam N., Abrahani M.A., St. Pierre E., Al-Atar O., Cam M.C., and Rodrigues B. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin. Arteriosclerosis, Thrombosis, and Vascular Biology 19 (1999) 1526-1534
54. Schulze C.J., Wang W., Suarez-Pinzon W.L., Sawicka J., Sawicki G., and Schulz R. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial. Circulation 107 (2003) 2487-2492
55. Sears C.E., Choate J.K., and Peterson D.J. Effect of nitric oxide synthase inhibition on the sympatho-vagal control of heart rate. Journal of the Autonomic Nervous System 73 (1998) 63-73
56. Southworth R., Blackburn S.C., Davey K.A., Sharland G.K., and Garlick P.B. The low oxygen-carrying capacity of Krebs buffer causes a doubling in ventricular wall thickness in the isolated heart. Canadian Journal of Physiology and Pharmacology 83 (2005) 174-182
57. Starling E.H., and Visscher M.B. The regulation of the energy output of the heart. Journal of Physiology 62 (1926) 243-261
58. Sutherland F.J., and Hearse D.J. The isolated blood and perfusion fluid perfused heart. Pharmacological Research 41 (2000) 613-627
59. Sutherland F.J., Shattock M.J., Baker K.E., and Hearse D.J. Mouse isolated perfused heart: characteristics and cautions. Clinical and Experimental Pharmacology and Physiology 30 (2003) 867-878
60. Suzuki K., Brand N.J., Smolenski R.T., Jayakumar J., Murtuza B., and Yacoub M.H. Development of a novel method for cell transplantation through the coronary artery. Circulation 102 (2000) 359-364
61. Suzuki K., Murtuza B., Fukushima S., Smolenski R.T., Varela-Carver A., Coppen S.R., et al. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation 110 (2004) 225-230
62. Taegtmeyer H. One hundred years ago: Oscar Langendorff and the birth of cardiac metabolism. Canadian Journal of Cardiology 11 (1995) 1030-1035
63. Tevaearai H.T., Walton G.B., Eckhart A.D., Keys J.R., and Koch W.J. Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated beta-adrenergic signaling modulation. European Journal of Cardio-Thoracic Surgery 22 (2002) 733-737
64. Valentin J.P., Hoffmann P., De Clerck F., Hammond T.G., and Hondeghem L. Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. Journal of Pharmacological and Toxicological Methods 49 (2004) 171-181
65. Verdouw P.D., van den Doel M.A., de Zeeuw S., and Duncker D.J. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovascular Research 39 (1998) 121-135
66. Wang W., Sawicki G., and Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovascular Research 53 (2002) 165-174
67. Wang W., Schulze C.J., Suarez-Pinzon W.L., Dyck J.R., Sawicki G., and Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106 (2002) 1543-1549
68. Wang Q.D., Tokuno S., Valen G., Sjoquist P.O., and Thoren P. Cyclic fluctuations in the cardiac performance of the isolated Langendorff-perfused mouse heart: pyruvate abolishes the fluctuations and has an anti-ischaemic effect. Acta Physiologica Scandinavica 175 (2002) 279-287
69. Yasmin W., Strynadka K.D., and Schulz R. Generation of peroxynitrite contributes to ischemia reperfusion injury in isolated rat hearts. Cardiovascular Research 33 (1997) 422-423
70. Ytrehus K. The ischemic heart-experimental models. Pharmacological Research 42 (2000) 193-203
71. Zaha V., Francischetti I., and Doenst T. Insulin improves postischemic recovery of function through PI3K in isolated working rat heart. Molecular and Cellular Biochemistry 247 (2003) 229-232
72. Zimmer H.G. The isolated perfused heart and its pioneers. News in Physiological Sciences 13 (1998) 203-210
73. Zimmer H.G. The contributions of Carl Ludwig to cardiology. Canadian Journal of Cardiology 15 (1999) 323-329
74. Zimmer H.G. Modifications of the isolated frog heart preparation in Carl Ludwig's Leipzig Physiological Institute: relevance for cardiovascular research. Canadian Journal of Cardiology 16 (2000) 61-69
75. Zimmer H.G. Who discovered the Frank-Starling mechanism?. News in Physiological Sciences 17 (2002) 181-184